USD 0.0
(33.33%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2022 | -369.00 USD | 49.86% |
2021 | -736.00 USD | 0.0% |
2012 | -527.37 Thousand USD | 26.81% |
2011 | -1.36 Million USD | -39.17% |
2010 | -465.62 Thousand USD | -45.05% |
2009 | -269.16 Thousand USD | -1030.49% |
2008 | 84.33 Thousand USD | 103.12% |
2007 | -1.58 Million USD | -120.27% |
2006 | -578.58 Thousand USD | -306.66% |
2005 | -258.92 Thousand USD | 83.13% |
2004 | -1.53 Million USD | -357.83% |
2003 | 595.34 Thousand USD | 220.66% |
2002 | -493.39 Thousand USD | 67.29% |
2001 | -1.5 Million USD | -3338.58% |
2000 | -421.42 Thousand USD | 107.5% |
1999 | -578.79 Thousand USD | -28.57% |
1998 | -483.16 Thousand USD | -114.52% |
1997 | -225.22 Thousand USD | -1636.92% |
1996 | -12.96 Thousand USD | 0.0% |
1994 | -24.26 Thousand USD | 7.37% |
1993 | -26.19 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2022 Q4 | -234.00 USD | 0.0% |
2022 FY | - USD | 49.86% |
2021 FY | - USD | 0.0% |
2012 Q1 | -628.83 Thousand USD | -21.97% |
2012 Q4 | -508.97 Thousand USD | -6834.24% |
2012 Q3 | -7340.00 USD | 98.61% |
2012 FY | - USD | 26.81% |
2012 Q2 | -528.24 Thousand USD | 16.0% |
2011 Q1 | -233.72 Thousand USD | 29.61% |
2011 Q3 | -447 Thousand USD | -206.64% |
2011 Q2 | -145.77 Thousand USD | 37.63% |
2011 FY | - USD | -39.17% |
2011 Q4 | -515.58 Thousand USD | -15.34% |
2010 Q3 | -386.94 Thousand USD | -75.54% |
2010 Q2 | -220.43 Thousand USD | -471.72% |
2010 FY | - USD | -45.05% |
2010 Q4 | -332.05 Thousand USD | 14.19% |
2010 Q1 | -38.55 Thousand USD | 62.38% |
2009 Q4 | -102.47 Thousand USD | -55.26% |
2009 Q1 | -211.19 Thousand USD | -134.37% |
2009 FY | - USD | -1030.49% |
2009 Q3 | -66 Thousand USD | 77.59% |
2009 Q2 | -294.56 Thousand USD | -39.48% |
2008 Q2 | -6845.00 USD | 98.73% |
2008 Q3 | 2622.00 USD | 138.31% |
2008 Q4 | 614.46 Thousand USD | 23335.01% |
2008 FY | - USD | 103.12% |
2008 Q1 | -537.78 Thousand USD | 24.29% |
2007 Q1 | -952.64 Thousand USD | 25.79% |
2007 Q2 | -754.74 Thousand USD | 20.77% |
2007 Q3 | 98.37 Thousand USD | 113.03% |
2007 Q4 | -710.28 Thousand USD | -822.03% |
2007 FY | - USD | -120.27% |
2006 Q2 | -57 Thousand USD | 0.0% |
2006 Q1 | -57 Thousand USD | 30.84% |
2006 FY | - USD | -306.66% |
2006 Q4 | -1.28 Million USD | -2152.2% |
2006 Q3 | -57 Thousand USD | 0.0% |
2005 Q4 | -82.42 Thousand USD | -44.6% |
2005 FY | - USD | 83.13% |
2005 Q1 | -57 Thousand USD | -189.75% |
2005 Q2 | -58.96 Thousand USD | -3.45% |
2005 Q3 | -57 Thousand USD | 3.33% |
2004 Q2 | -78.33 Thousand USD | -12.04% |
2004 Q3 | -1.36 Million USD | -1645.08% |
2004 FY | - USD | -357.83% |
2004 Q1 | -69.92 Thousand USD | -108.2% |
2004 Q4 | -19.67 Thousand USD | 98.56% |
2003 Q2 | -81.04 Thousand USD | -124.43% |
2003 Q4 | 852.9 Thousand USD | 707.4% |
2003 Q3 | -140.42 Thousand USD | -73.26% |
2003 Q1 | -36.11 Thousand USD | 83.78% |
2003 FY | - USD | 220.66% |
2002 FY | - USD | 67.29% |
2002 Q3 | -17.31 Thousand USD | 12.03% |
2002 Q4 | -222.63 Thousand USD | -1185.95% |
2002 Q1 | -208.76 Thousand USD | 77.01% |
2002 Q2 | -19.68 Thousand USD | 90.57% |
2001 FY | - USD | -3338.58% |
2001 Q2 | -3713.00 USD | 99.32% |
2001 Q3 | -48.79 Thousand USD | -1214.09% |
2001 Q1 | -545.81 Thousand USD | -302.52% |
2001 Q4 | -925.45 Thousand USD | -1761.03% |
2000 Q1 | -74.53 Thousand USD | 0.0% |
2000 FY | - USD | 107.5% |
2000 Q4 | -198.6 Thousand USD | 443.56% |
2000 Q3 | -79.33 Thousand USD | -13.76% |
2000 Q2 | -68.95 Thousand USD | 7.48% |
1999 FY | - USD | -28.57% |
1999 Q1 | -1553.00 USD | 0.0% |
1998 FY | - USD | -114.52% |
1997 FY | - USD | -1636.92% |
1996 FY | - USD | 0.0% |
1994 FY | - USD | 7.37% |
1993 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Achiko AG | -8.32 Million USD | 99.996% |
Accelera Innovations, Inc | - USD | Infinity% |
Aspyra Inc. | -2.84 Million USD | 99.987% |
Cannabis Sativa, Inc. | -1.11 Million USD | 99.967% |
CompuMed, Inc. | 690.19 Thousand USD | 100.053% |
CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.0% |
Cogstate Limited | 9.89 Million USD | 100.004% |
CareView Communications, Inc. | -210.04 Thousand USD | 99.824% |
Craneware plc | 54.26 Million USD | 100.001% |
Caduceus Software Systems Corp. | -12.29 Million USD | 99.997% |
Certive Solutions Inc. | -704.66 Thousand USD | 99.948% |
Drug Free Solution, Inc. | -1.39 Million USD | 99.974% |
DATATRAK International, Inc. | 2.72 Million USD | 100.014% |
Strainsforpains, Inc. | -65.61 Thousand USD | 99.438% |
Healixa Inc. | -6.32 Million USD | 99.994% |
Easy Technologies Inc. | - USD | Infinity% |
eWellness Healthcare Corporation | - USD | Infinity% |
Founders Bay Holdings | 10.16 Million USD | 100.004% |
Health Discovery Corporation | - USD | Infinity% |
Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | 99.913% |
H-Source Holdings Ltd. | - USD | Infinity% |
InterCare DX, Inc. | - USD | Infinity% |
IQ-AI Limited | -370.35 Thousand USD | 99.9% |
Cannabiz Mobile, Inc. | -750.00 USD | 50.8% |
Mednow Inc. | -28.12 Million USD | 99.999% |
Galileo Life Sciences, Inc. | -270.72 Thousand USD | 99.864% |
MediXall Group, Inc. | -6.52 Million USD | 99.994% |
Mitesco, Inc. | -11.96 Million USD | 99.997% |
MobileSmith, Inc. | -13.83 Million USD | 99.997% |
NantHealth, Inc. | -38.53 Million USD | 99.999% |
Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 99.978% |
OneLife Technologies Corp. | - USD | Infinity% |
ORHub, Inc. | -12.08 Million USD | 99.997% |
Patient Access Solutions, Inc. | -12.09 Million USD | 99.997% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | 100.028% |
PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 100.494% |
Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | 96.971% |
Renalytix Plc | -28.52 Million USD | 99.999% |
Revium Recovery Inc. | -678 Thousand USD | 99.946% |
RYAH Group, Inc. | - USD | Infinity% |
Vaso Corporation | 4.19 Million USD | 100.009% |
Vynleads, Inc. | -235.72 Thousand USD | 99.843% |